Current Ratio of aTYR PHARMA INC from 30 Sep 2015 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
aTYR PHARMA INC quarterly Current Ratio in x history and change rate from 30 Sep 2015 to 31 Dec 2025.
- aTYR PHARMA INC Current Ratio for the quarter ending 31 Dec 2025 was 6.03x, a 0.67% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
aTYR PHARMA INC Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 6.03x | -0.04x | -0.67% | 31 Dec 2025 |
| Q3 2025 | 6.08x | -0.2x | -3.2% | 30 Sep 2025 |
| Q2 2025 | 5.95x | -1.01x | -15% | 30 Jun 2025 |
| Q1 2025 | 6.43x | -0.88x | -12% | 31 Mar 2025 |
| Q4 2024 | 6.07x | -1.96x | -24% | 31 Dec 2024 |
| Q3 2024 | 6.28x | -1.72x | -21% | 30 Sep 2024 |
| Q2 2024 | 6.96x | -0.86x | -11% | 30 Jun 2024 |
| Q1 2024 | 7.31x | -0.57x | -7.2% | 31 Mar 2024 |
| Q4 2023 | 8.03x | -0.89x | -9.9% | 31 Dec 2023 |
| Q3 2023 | 8x | -4.05x | -34% | 30 Sep 2023 |
| Q2 2023 | 7.82x | -7.96x | -50% | 30 Jun 2023 |
| Q1 2023 | 7.88x | -7.27x | -48% | 31 Mar 2023 |
| Q4 2022 | 8.91x | -5.24x | -37% | 31 Dec 2022 |
| Q3 2022 | 12.05x | +1.13x | +10% | 30 Sep 2022 |
| Q2 2022 | 15.77x | +9.05x | +135% | 30 Jun 2022 |
| Q1 2022 | 15.15x | +9.12x | +151% | 31 Mar 2022 |
| Q4 2021 | 14.16x | +9.24x | +188% | 31 Dec 2021 |
| Q3 2021 | 10.92x | +6.93x | +174% | 30 Sep 2021 |
| Q2 2021 | 6.72x | +3.05x | +83% | 30 Jun 2021 |
| Q1 2021 | 6.03x | +2.47x | +70% | 31 Mar 2021 |
| Q4 2020 | 4.92x | +1.54x | +46% | 31 Dec 2020 |
| Q3 2020 | 3.99x | +0.03x | +0.85% | 30 Sep 2020 |
| Q2 2020 | 3.67x | -0.8x | -18% | 30 Jun 2020 |
| Q1 2020 | 3.56x | -1.45x | -29% | 31 Mar 2020 |
| Q4 2019 | 3.38x | -2.36x | -41% | 31 Dec 2019 |
| Q3 2019 | 3.96x | -2.68x | -40% | 30 Sep 2019 |
| Q2 2019 | 4.48x | -3.13x | -41% | 30 Jun 2019 |
| Q1 2019 | 5x | -2.7x | -35% | 31 Mar 2019 |
| Q4 2018 | 5.74x | -2.58x | -31% | 31 Dec 2018 |
| Q3 2018 | 6.63x | -1.78x | -21% | 30 Sep 2018 |
| Q2 2018 | 7.61x | +0.21x | +2.8% | 30 Jun 2018 |
| Q1 2018 | 7.71x | +0.42x | +5.8% | 31 Mar 2018 |
| Q4 2017 | 8.32x | +1.55x | +23% | 31 Dec 2017 |
| Q3 2017 | 8.42x | +1.67x | +25% | 30 Sep 2017 |
| Q2 2017 | 7.4x | -0.57x | -7.2% | 30 Jun 2017 |
| Q1 2017 | 7.28x | -1.99x | -21% | 31 Mar 2017 |
| Q4 2016 | 6.77x | -2.09x | -24% | 31 Dec 2016 |
| Q3 2016 | 6.74x | -0.52x | -7.2% | 30 Sep 2016 |
| Q2 2016 | 7.97x | 30 Jun 2016 | ||
| Q1 2016 | 9.27x | 31 Mar 2016 | ||
| Q4 2015 | 8.86x | 31 Dec 2015 | ||
| Q3 2015 | 7.27x | 30 Sep 2015 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.